Biosil is built on ch-OSA, a patented bioavailable form of silicon that helps the body generate its own collagen. The category around it is poisoned: the loudest search results say collagen supplements do not work, and the brand ranked #10 on its own molecule. This is how Forge built the authority network that takes it back, one compliant page at a time.
Search for the molecule and the brand ranked #10 with one thin page. Search for the informational questions around it and a competitor answered them. The store itself lived on a temporary subdomain where serious SEO is structurally impossible.
Meanwhile the entire category carries a credibility tax: the dominant narrative in search is that collagen supplements are ineffective, which is precisely why a molecule that works differently needed its own explained territory.
Instead of competing on "collagen supplements", the strategy occupies the space nobody holds: bioavailable silicon, explained scientifically, with the molecule's own clinical evidence and its limits stated in plain sight.
The site is built as a science reference with three audiences, patients, practitioners and distributors, rather than as a shop shouting claims.
Full migration of the store: 6 pillar pages, 40 articles, 34 metafield definitions and every image re-hosted, completed July 6, 2026.
One page that makes the molecule machine-readable: what it is, how it is thought to work, what the evidence does and does not show, patent and registry identifiers included, so search engines and AI assistants can resolve the entity to its owner.
The dental cluster, 6 sub-pillars and 40 satellite articles, and the skin cluster, 2 hubs and 8 sub-pillars, all live and verified, with the satellites dripped one per working day so the site grows every day for eight weeks.
Every page is supplement-regulation safe by design: a blacklist of claim verbs, a per-study evidence table with mandatory caveats, and an automated quality check on every page, 8 of 8 checks passing. In a category where overclaiming is the norm, restraint is the moat.
The center of the network: the molecule explained on the brand's own domain, with the evidence stated honestly, and every cluster page linking up to it.

Not on this page yet, on purpose. The publication drip completes on September 11, 2026, and search data on a network this young would be noise dressed as proof. This page reports the build, which is what was sold and delivered. When a clean measurement window exists, the search results will be added here with their sources, the same way every Forge case study reports numbers. If they disappoint, they will be published too.
Migration completed July 6. Skin cluster live July 17. Drip from July 20 to September 11. Every deliverable on this page is verifiable on the live site.
Zero traffic or revenue claims until a clean window exists. A case study that cannot wait for its own data is an ad.
Every health claim on the delivered pages is sourced and caveated. The same discipline applies to this page.
Because authority is topical, not page-by-page. The plan covers 6 sections and 24 clusters around the molecule's real uses, so that every question a patient or practitioner asks resolves to the brand's own domain instead of a competitor or a skeptic.
With hard guardrails: a blacklist of forbidden claim verbs, an evidence table that forces a caveat on every cited study, and an automated check on every page before publication. Restraint written into the process, not left to the writer's mood.
A site that grows daily for eight weeks gives search engines a fresh reason to return, and spreads the indexing load instead of dumping 40 URLs in one crawl. The drip runs July 20 to September 11, 2026.
On the call we map the search territory around your product and show you which questions your buyers ask that nobody answers yet.
Book a call and see the method live